Cargando…

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms

Detalles Bibliográficos
Autores principales: Pinkerton, JoAnn V, Redick, Dana L, Homewood, Laura N, Kaunitz, Andrew M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583986/
https://www.ncbi.nlm.nih.gov/pubmed/37097747
http://dx.doi.org/10.1210/clinem/dgad209
_version_ 1785122663263371264
author Pinkerton, JoAnn V
Redick, Dana L
Homewood, Laura N
Kaunitz, Andrew M
author_facet Pinkerton, JoAnn V
Redick, Dana L
Homewood, Laura N
Kaunitz, Andrew M
author_sort Pinkerton, JoAnn V
collection PubMed
description
format Online
Article
Text
id pubmed-10583986
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105839862023-10-19 Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms Pinkerton, JoAnn V Redick, Dana L Homewood, Laura N Kaunitz, Andrew M J Clin Endocrinol Metab Commentary Oxford University Press 2023-04-25 /pmc/articles/PMC10583986/ /pubmed/37097747 http://dx.doi.org/10.1210/clinem/dgad209 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Commentary
Pinkerton, JoAnn V
Redick, Dana L
Homewood, Laura N
Kaunitz, Andrew M
Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title_full Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title_fullStr Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title_full_unstemmed Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title_short Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
title_sort neurokinin receptor antagonist, fezolinetant, for treatment of menopausal vasomotor symptoms
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583986/
https://www.ncbi.nlm.nih.gov/pubmed/37097747
http://dx.doi.org/10.1210/clinem/dgad209
work_keys_str_mv AT pinkertonjoannv neurokininreceptorantagonistfezolinetantfortreatmentofmenopausalvasomotorsymptoms
AT redickdanal neurokininreceptorantagonistfezolinetantfortreatmentofmenopausalvasomotorsymptoms
AT homewoodlauran neurokininreceptorantagonistfezolinetantfortreatmentofmenopausalvasomotorsymptoms
AT kaunitzandrewm neurokininreceptorantagonistfezolinetantfortreatmentofmenopausalvasomotorsymptoms